Cystic fibrosis: home antibiotic therapy

被引：0
作者：
Lenoir, G [1 ]
Monnier, A [1 ]
Marais, P [1 ]
机构：
[1] Hop Necker Enfants Malad, Serv Pediat Gen, F-75743 Paris 15, France
来源：
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE | 1999年 / 39卷 / 06期
关键词：
cystic fibrosis; antibiotics; home therapy;
D O I：
10.1016/S0335-7457(99)80134-8
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：520 / 522
页数：3
相关论文
共 50 条
  • [41] Cytokine pattern in cystic fibrosis patients during antibiotic therapy and gene therapy using adenoviral vector
    Reix, P
    Bellon, G
    Bienvenu, J
    Pavirani, A
    Levrey-Hadden, N
    EUROPEAN CYTOKINE NETWORK, 2002, 13 (03) : 324 - 330
  • [42] Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany
    Naehrig, S.
    Schulte-Hubbert, B.
    Hafkemeyer, S.
    Hammermann, J.
    Dumke, M.
    Sieber, S.
    Naehrlich, L.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 80
  • [43] Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?
    Horsley, Alex
    Webb, Kevin
    Bright-Thomas, Rowland
    Govan, John
    Jones, Andrew
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2011, 1 : 18
  • [44] Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis
    Durieu, I.
    Abbas-Chorfa, F.
    Drai, J.
    Iwaz, J.
    Steghens, J-P.
    Puget, M.
    Ecochard, R.
    Belllon, G.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (05) : 958 - 964
  • [45] The problems of antibiotic resistance in cystic fibrosis and solutions
    Lopez-Causape, Carla
    Rojo-Molinero, Estrella
    Macia, Maria D.
    Oliver, Antonio
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (01) : 73 - 88
  • [46] Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials
    Mayer-Hamblett, Nicole
    Saiman, Lisa
    Lands, Larry C.
    Anstead, Michael
    Rosenfeld, Margaret
    Kloster, Margaret
    Fisher, Leigh
    Ratjen, Felix
    CONTEMPORARY CLINICAL TRIALS, 2013, 36 (01) : 99 - 105
  • [47] Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: A meta-analysis of benefits and risks
    Mukhopadhyay, S
    Singh, M
    Cater, JI
    Ogston, S
    Franklin, M
    Olver, RE
    THORAX, 1996, 51 (04) : 364 - 368
  • [48] Improvement of nebulised antibiotic delivery in cystic fibrosis
    Wilson, D
    Bruniston, M
    Moya, E
    Parkin, A
    Smye, S
    Robinson, P
    Littlewood, J
    ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 80 (04) : 348 - 352
  • [49] Intravenous peripherally-inserted central catheters for antibiotic therapy in children with cystic fibrosis
    Bui, S.
    Babre, F.
    Hauchecorne, S.
    Christoflour, N.
    Ceccato, F.
    Boisserie-Lacroix, V.
    Clouzeau, H.
    Fayon, M.
    JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (05) : 326 - 331
  • [50] Comparison of home and hospital intravenous antibiotic therapy for clinical outcome in patients with a pulmonary exacerbation of cystic fibrosis. Do they always need to be admitted?
    Saad, Emad Y.
    Leung, Winnie M.
    Smith, Maeve P.
    Salgado, Josette
    Hassan, Imran
    Brown, Neil E.
    CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2018, 2 (03) : 133 - 137
12345